Ganoderma lucidum (Reishi mushroom) for cancer treatment

Abstract

ects of ganopoly (a Ganoderma lucidum polysaccharide extract) on the immune functions in advanced-stage cancer patients. Immunological

Preliminary Efficacy and Safety of Reishi & Privet Formula on Quality of Life Among Non–Small Cell Lung Cancer Patients Undergoing Chemotherapy: A Randomized Placebo-Controlled Trial

“…A meta-analysis of clinical results showed similar evidence that Reishi mushroom (Lingzhi) was generally well tolerated with minimal side effects including nausea and insomnia, and no reports of significant hematological or hepatological toxicity. 30 Although we did not observe any sign of RPF preventing objective adverse events such as neutropenia, anemia, or thrombocytopenia, we did observe that a greater proportion of patients in the RPF group who experienced fatigue at the start of chemotherapy were able to either maintain or reduce their fatigue during the rest of treatment. This might indicate that RPF has the potential to reduce chemotherapy-induced fatigue.…”

Preliminary Efficacy and Safety of Reishi & Privet Formula on Quality of Life Among Non–Small Cell Lung Cancer Patients Undergoing Chemotherapy: A Randomized Placebo-Controlled Trial

“…A meta-analysis of clinical results showed similar evidence that Reishi mushroom (Lingzhi) was generally well tolerated with minimal side effects including nausea and insomnia, and no reports of significant hematological or hepatological toxicity. 30 Although we did not observe any sign of RPF preventing objective adverse events such as neutropenia, anemia, or thrombocytopenia, we did observe that a greater proportion of patients in the RPF group who experienced fatigue at the start of chemotherapy were able to either maintain or reduce their fatigue during the rest of treatment. This might indicate that RPF has the potential to reduce chemotherapy-induced fatigue.…”

The Promising Role of Mushrooms as a Therapeutic Adjuvant of Conventional Cancer Therapies

“…The included studies suggest that mushrooms can increase NK cells [23,24]. This observation was previously described in a Cochrane systematic review [31].…”

B-glucans from Grifola frondosa and Ganoderma lucidum in breast cancer: an example of complementary and integrative medicine

“…Therapeutic approaches that incorporate G. lucidum are 1.25 times more likely to yield better tumor response than those do not. Further, G. lucidum preparations can be administered in order to counter the immunosuppressive effects of CT and RT [ 9 ], especially in terms of T-lymphocyte depletion. Similar to other natural remedies, G. lucidum is well-tolerated by cancer patients, which leads to better QoL and relatively improved Performance Status (Karnofsky) scores.…”

Preliminary Efficacy and Safety of Reishi & Privet Formula on Quality of Life Among Non–Small Cell Lung Cancer Patients Undergoing Chemotherapy: A Randomized Placebo-Controlled Trial

“…A meta-analysis of clinical results showed similar evidence that Reishi mushroom (Lingzhi) was generally well tolerated with minimal side effects including nausea and insomnia, and no reports of significant hematological or hepatological toxicity. 30 Although we did not observe any sign of RPF preventing objective adverse events such as neutropenia, anemia, or thrombocytopenia, we did observe that a greater proportion of patients in the RPF group who experienced fatigue at the start of chemotherapy were able to either maintain or reduce their fatigue during the rest of treatment. This might indicate that RPF has the potential to reduce chemotherapy-induced fatigue.…”

The Promising Role of Mushrooms as a Therapeutic Adjuvant of Conventional Cancer Therapies

“…The included studies suggest that mushrooms can increase NK cells [23,24]. This observation was previously described in a Cochrane systematic review [31].…”

B-glucans from Grifola frondosa and Ganoderma lucidum in breast cancer: an example of complementary and integrative medicine

“…Therapeutic approaches that incorporate G. lucidum are 1.25 times more likely to yield better tumor response than those do not. Further, G. lucidum preparations can be administered in order to counter the immunosuppressive effects of CT and RT [ 9 ], especially in terms of T-lymphocyte depletion. Similar to other natural remedies, G. lucidum is well-tolerated by cancer patients, which leads to better QoL and relatively improved Performance Status (Karnofsky) scores.…”

Preliminary Efficacy and Safety of Reishi & Privet Formula on Quality of Life Among Non–Small Cell Lung Cancer Patients Undergoing Chemotherapy: A Randomized Placebo-Controlled Trial

“…A meta-analysis of clinical results showed similar evidence that Reishi mushroom (Lingzhi) was generally well tolerated with minimal side effects including nausea and insomnia, and no reports of significant hematological or hepatological toxicity. 30 Although we did not observe any sign of RPF preventing objective adverse events such as neutropenia, anemia, or thrombocytopenia, we did observe that a greater proportion of patients in the RPF group who experienced fatigue at the start of chemotherapy were able to either maintain or reduce their fatigue during the rest of treatment. This might indicate that RPF has the potential to reduce chemotherapy-induced fatigue.…”

The Promising Role of Mushrooms as a Therapeutic Adjuvant of Conventional Cancer Therapies

“…The included studies suggest that mushrooms can increase NK cells [23,24]. This observation was previously described in a Cochrane systematic review [31].…”

B-glucans from Grifola frondosa and Ganoderma lucidum in breast cancer: an example of complementary and integrative medicine

“…Therapeutic approaches that incorporate G. lucidum are 1.25 times more likely to yield better tumor response than those do not. Further, G. lucidum preparations can be administered in order to counter the immunosuppressive effects of CT and RT [ 9 ], especially in terms of T-lymphocyte depletion. Similar to other natural remedies, G. lucidum is well-tolerated by cancer patients, which leads to better QoL and relatively improved Performance Status (Karnofsky) scores.…”